Skip to main content
SpringerLink
Log in

Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

We analysed p53 protein immunoreactivity in hepatocellular carcinomas (HCCs) and in liver cell dysplasia (LCD) of patients from an area in Northern China, using five anti-p53 protein antibodies recognizing different epitopes of the protein. In HCCs, the overall prevalence of p53 protein immunoreactivity was 78.3%. However, prevalence was strongly influenced by the type of antibody used, ranging from 67.5% for antibody PAb-1801 to only 10.8% for antibodies PAb-421 and DO-7. p53 protein immunoreactivity was not related to type or grade of HCC. In contrast to former reports, p53 protein staining was restricted to nuclei only when using the CM-1 antibody, whereas two other antibodies yielded both, nuclear and cytoplasmic or membrane staining, and no nuclear staining was observed with antibodies PAb-421 and DO-7, the latter two, however, demonstrating cytoplasmic and membrane staining. For LCD, three subtypes were morphologically and karyometrically defined. Nuclei of some LCD cells were p53 immunoreactive, but positivity was restricted to the small cell variant of LCD. Positivity was different for cirrhosis with or without associated HCC, amounting to 18.9% in the former and 39.4% in the latter. Interestingly, p53 protein immunoreactivity also occurred in a set of small hepatocytes not showing the typical features of LCD and therefore classified as simple regenerating liver cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anthony PP (1976) Precursor lesions for liver cancer in humans. Cancer Res 46:2579–2583

    Google Scholar 

  2. Banks L, Matlashewski G, Crawford L (1986) Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159:529–534

    Google Scholar 

  3. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J et al. (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699–1703

    CAS  PubMed  Google Scholar 

  4. Braun L, Mikumo R, Fausto N (1986) Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res 49:1554–1561

    Google Scholar 

  5. Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 350:429–431

    Google Scholar 

  6. Buetow KH, Sheffield VC, Zhu M, Zhou T, Shen FM, Hino O, Smith M, McMahon BJ, Lanier AP, London WT, Redeker AG, Govindarajan S (1992) Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. Proc Natl Acad Sci USA 89:9622–9626

    Google Scholar 

  7. Challen C, Lunec J, Warren W, Collier J, Bassendine MF (1992) Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 16:1362–1366

    Google Scholar 

  8. Choi SW, Hytiroglou P, Geller SA, Kim SM, Chung KW, Park DH, Theise ND, Thung SN (1993) The expression of p53 antigen in primary malignant epithelial tumors of the liver: an immunohistochemical study. Liver 13:172–176

    Google Scholar 

  9. Coltrera MD, Zarbo RJ, Sakr WA, Grown AM (1992) Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol 141:817–825

    Google Scholar 

  10. Coltrera MD, Skelly M, Gown AM (1993) Anti-PCNA antibody PC10 yields unreliable proliferation indexes in routinely processed, deparaffinized, formalin-fixed tissue. Appl Immunohistochem 1:193–200

    Google Scholar 

  11. Conte D, Neri A, Lodi L, Croce LS, Fraquelli M, Masutti F, Tiribelli C (1993) p53 and H- and K-ras in hepatocellular carcinoma (HCC). Data from an area at intermediate HCC prevalence (abstract). Hepatology 18:182

    Google Scholar 

  12. Donehower LA, Bradley A (1993) The tumour suppressor p53. Biochim Biophys Acta 1155:181–205

    Google Scholar 

  13. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 7:462–503

    PubMed  Google Scholar 

  14. Ferrell L, Crawford JM, Dhillon AP, Scheuer PJ, Nakanuma Y (1993) Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 17:1113–1123

    Google Scholar 

  15. Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H (1988) Macroregenerative nodules of the liver: a clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 61:99–105

    Google Scholar 

  16. Gannon JV, Greaves R, Iggo R, Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595–1602

    Google Scholar 

  17. Gelb AB, Kamel OW, LeBrun DP, Warnke RA (1992) Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/cyclin monoclonal antibodies. Factors affecting reactivity. Am J Pathol 141:1453–1458

    Google Scholar 

  18. Gibson JB, Sobin LH (1978) Histological typing of tumours of the liver, biliary tract and pancreas. International histological classification of tumours 20. World Health Organization, Geneva

    Google Scholar 

  19. Hayashi H, Sugio K, Matsumata T, Adachi E, Urata K, Tanaka S, Sugimachi K (1993) The mutation of codon 249 in the p53 gene is not specific in Japanese hepatocellular carcinoma. Liver 13:279–281

    CAS  PubMed  Google Scholar 

  20. Hayward NK, Walker GJ, Graham W, Cooksley E (1991) Hepatocellular carcinoma mutation. Nature 352:764

    Google Scholar 

  21. Hofmann WJ, Volkmann M, Haag D, Otto G, Galle PR (1993) p53 overexpression in HCC is correlated with the proliferative activity but not with EGF-R expression of the tumors (abstract). Hepatology 18:185

    Google Scholar 

  22. Hollstein MC, Wild CP, Bleicher F, Chutimataewin S, Harris CC, Srivatanakul P, Montesano R (1993) p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer 53:51–55

    Google Scholar 

  23. Hosono S, Lee CS, Chou MJ, Yang CS, Shih CH (1991) Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene 6:237–243

    Google Scholar 

  24. Hsia CC, Kleiner DE, Axiotis CA, DiBisceglie A, Nomura AMY, Stemmermann GN, Tabor E (1992) Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst 84:1638–1641

    Google Scholar 

  25. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428

    Google Scholar 

  26. Hulla JE, Chen ZY, Eaton DL (1993) Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Cancer Res 53:9–11

    Google Scholar 

  27. Kaklamanis L, Gatter KC, Mortensen N, Baigrie RJ, Heryet A, Lane DP, Harris AL (1993) p53 expression in colorectal adenomas. Am J Pathol 142:87–93

    Google Scholar 

  28. Kamel D, Pääkö P, Nuorva K, Vähäkangas K, Soini Y (1993) p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder. J Pathol 170:67–72

    Google Scholar 

  29. Kar S, Jaffe R, Carr BI (1993) Mutation at codon 249 of p53 gene in a human hepatoblastoma. Hepatology 18:566–569

    Google Scholar 

  30. Kitamoto M, Nakanishi T, Kira S, Kawaguchi M, Nakashio R, Suemori S, Kajiyama G, Asahara T, Dohi K (1993) The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 72:1859–1865

    Google Scholar 

  31. Koukoulis G, Rayner A, Tan KC, Williams R, Portmann B (1992) Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol 166:359–368

    Google Scholar 

  32. Kress S, Jahn UR, Buchmann A, Bannasch P, Schwarz M (1992) p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res 52:3220–3223

    Google Scholar 

  33. Laurent-Puig P, Flejou JF, Fabre M, Bedossa P, Belghiti J, Gayral F, Franco D (1992) Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology 16:1171–1175

    Google Scholar 

  34. Li ZS (1990) Analysis of DNA content of cell from liver cells dysplasia and hepatocellular carcinoma. Chung-hua Ping Li Hsueh Tsa Chih 19:215–217

    Google Scholar 

  35. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM (1992) Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 101:67–74

    Google Scholar 

  36. Moll UM, Riou G, Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262–7266

    Google Scholar 

  37. Murakami Y, Hayashi K, Hirohashi S et al. (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51:5520–5525

    Google Scholar 

  38. Nakanuma Y, Terada T, Terasaki S, Ueda K, Nonomura A, Kawahara E, Matsui O (1990) “Atypical adenomatous hyperplasia” in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion? Histopathology 17:27–35

    Google Scholar 

  39. Nakashima T, Kojiro M (1987) Hepatocellular carcinoma. An atlas of its pathology. Springer Verlag, Tokyo, Berlin Heidelberg New York

    Google Scholar 

  40. Ng IOL, Chung LP, Tsang S, Lam CL, Lai ECS, Fan ST, Ng MMT (1993) p53 gene mutation spectrum in hepatocellular carcinoma in Hong Kong Chinese (abstract). Hepatology 18:191

    Google Scholar 

  41. Ng IOL, Lai ECS, Fan ST, Ng MMT, Chan ASY, So MKP (1993) Expression of proliferating cell nuclear antigen in hepatocellular carcinoma (abstract). Hepatology 18:191

    Google Scholar 

  42. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenaga M, Imura H, Ishizaki K (1993) Role and mutational heterogeneity of p53 in hepatocellular carcinoma. Cancer Res 53:368–372

    Google Scholar 

  43. Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli J, Vähäkangas K, Pääkö P (1993) Concurrent p53 expression in bronchial dysplasia and squamous cell lung carcinomas. Am J Pathol 142:725–732

    Google Scholar 

  44. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S (1992) Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res 52:3674–3678

    Google Scholar 

  45. Oren M (1992) p53: the ultimate tumor suppressor gene? FASEB J 6:3169–3176

    Google Scholar 

  46. Ozturk M, Bressac B, Kew M, Volkman M, Bozcall S, Kar S, Carr BI (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338:1356–1359

    Google Scholar 

  47. Paterson AC, Kew MC, Dusheiko GM, Isaacson C (1989) Liver cell dysplasia accompanying hepatocellular carcinoma in Southern Africa. Differences between urban and rural populations. J Hepatol 8:241–248

    Google Scholar 

  48. Rugge M, Shiao YH, Correa P, Baffa R, DiMario F (1992) Immunohistochemical evidence for p53 overexpression in gastric epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 1:551–554

    Google Scholar 

  49. Scorsone KA, Zhou YZ, Butel JS, Slagle BL (1992) p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 52:1635–1638

    Google Scholar 

  50. Sheu JC, Huang GT, Lee PH, Chung JC, Chou HC, Lai MY, Wang JT, Lee HS, Shih LN, Yang PM, Wang TH, Chen DS (1992) Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res 52:6098–6100

    Google Scholar 

  51. Tabor E, Hsia CC, Muchmore E (1993) Hepatocellular carcinoma (HCC) in two chimpanzees; studies of transforming growth factor alpha (TGF alpha) and p53, and detection of oval cells (abstract). Hepatology 18:194

    Google Scholar 

  52. Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, Kuni Y, Okamoto N, Inoue T, Kanisawa M (1992) Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology 103:595–600

    Google Scholar 

  53. Terris B, Marcio A, Tiollais P, Dejean A (1993) The p53 gene in human hepatocellular carcinomas. J Hepatol 17:422

    Google Scholar 

  54. Tezuka F, Sawai T (1983) Hyperplasia of small hepatic cells in the precancerous condition of cirrhotic livers. Tohoku J Exp Med 139:171–177

    Google Scholar 

  55. Thomas RM, Bermann JJ, Yetter RA, Moore W, Hutchins GM (1992) Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features. Hum Pathol 23:496–504

    Google Scholar 

  56. Thompson NL, Mead JE, Braun L, Goyette M, Shank PR, Fausto N (1985) Sequential protooncogene expression during rat liver regeneration. Cancer Res 46:3111–3117

    Google Scholar 

  57. Vojtesek B, Lane DP (1993) Regulation of p53 protein expression in human breast cancer cell lines. J Cell Sci 105:607–612

    Google Scholar 

  58. Vojtesek B, Bartek J, Midgley CA, Lane DP (1992) An immunohistochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. Immunol Methods 151:237–244

    Google Scholar 

  59. Volkmann M, Hoffmann WJ, Müller M, Klein R, Willemann B, Zentgraf H, Räth U, Galle PR (1993) p53 in European hepatocellular carcinoma: genomic alterations associated with increased steady state levels and heterogenous functional characteristics in vitro (abstract). Hepatology 18:196

    Google Scholar 

  60. Wade-Evans A, Jenkins AR (1985) Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J 4:699–706

    Google Scholar 

  61. Wang LD, Hong JY, Qui SL, Gao H, Yang CS (1993) Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53:1783–1787

    Google Scholar 

  62. Watanabe S, Okita S, Harada T, Kodama T, Numa Y, Takemoto T, Takahashi T (1983) Morphologic studies of the liver cell dysplasia. Cancer 51:2197–2205

    Google Scholar 

  63. Zambetti GP, Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855–865

    Google Scholar 

  64. Zhao M, Zhang NX, Du ZY, Laissue JL, Zimmermann A (1994) Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma. Histol Histopath 9:73–83

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, University of Bern, Murtenstrasse 31, CH-3010, Bern, Switzerland

    M. Zhao, J. A. Laissue & A. Zimmermann

  2. Department of Pathology, Tianjin Medical College, Tianjin, China

    N -X. Zhang

Authors
  1. M. Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. A. Laissue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N -X. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, M., Laissue, J.A., Zimmermann, A. et al. Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma. Vichows Archiv A Pathol Anat 424, 613–621 (1994). https://doi.org/10.1007/BF00195775

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00195775

Key words

Search

Navigation